Form 483

Epic Pharma, LLC Form 483, 2010-11-16

FDA issued a Form 483 to Epic Pharma, LLC on 2010-11-16 with 4 public-safe observations.

483· Form 483 issued4 observations

Epic Pharma, LLC · Laurelton, United States · Issued November 16, 2010

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

16 Nov 2010
21 CFR 211.25(a)

Training , Education , Experience overall

Cited by Alice S Tsao

16 Nov 2010
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Alice S Tsao

16 Nov 2010
21 CFR 211.170(b)

Annual visual exams of drug products

Cited by Alice S Tsao

16 Nov 2010
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Alice S Tsao

Inspected site

EPEpic Pharma, LLCLaurelton, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.170(b)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere